an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vessel Preparation Facilitated by IVUS on the Lower Limb Ischemia Patients With Calcified Lesions

Sponsor
The First Affiliated Hospital of Dalian Medical University
Study ID
NCT07397390
Status
Enrolling By Invitation

Conditions

  • Angioplasty
  • Calcifications, Vascular
  • Cutting Balloon Angioplasty
  • Femoral Artery Stenosis
  • Infrapopliteal Arterial Occlusive Disease
  • Intravascular Imaging Device
  • Peripheral Artery Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • DKutting LL scoring balloon angioplasty — DEVICE
    Following the detection of calcified lesions by Intravascular Ultrasound (IVUS), and aided by its accurate measurements of lesion diameter and length, percutaneous transluminal angioplasty (PTA) was performed using the DKutting LL scoring balloon

Study Details

This is a prospective, single-center, single-arm, observational study. It plans to enroll 58 patients with moderate to severely calcified lesions in the femoropopliteal or infrapopliteal arteries. Participants will be treated with the Scoring Balloon Dilatation Catheter manufactured by DK Medtech (Suzhou) Co., Ltd. The study aims to evaluate the immediate technical success rate and the improvement in lumen area and calcification burden as assessed by IVUS following percutaneous transluminal angioplasty with the scoring balloon. Clinical follow-ups will be conducted at discharge (or within 7 days), 1 month, 3 months, and 6 months post-procedure to observe secondary endpoints including the incidence of clinically driven target lesion revascularization and changes in Rutherford classification

Key Dates

First listed
Feb 9, 2026
Start date
Mar 17, 2026
Status verified
Apr 2026
Primary completion
Dec 30, 2026
Completion
Mar 30, 2027

Study Design

Enrollment
58 participants (estimated)

Arms

  • Arm: Dkutting LL treatment group
    IVUS facilitated DKutting LL angioplasty

Primary Outcome Measure

primary effectiveness outcome [ Time Frame: immediately after the intervention ]

Find similar trials

Related Studies